2010-2015: PhD; Biological Sciences in Dental Medicine, The Graduate School of Arts and Sciences, Harvard University 2005-2008: Master of Medicine Degree; Major in Oral & Maxillofacial Surgery Peking University Health Science Center, Beijing, P.R. China 2000-2005: Bachelor of Medicine in Dentistry, Zhengzhou University School of Stomatology, Zhengzhou, P.R. China 2017: present Clinical training in the Advanced Standing DMD Program in Boston University School of dental medicine Graduate Research Assistant Dr. Bjorn Olsen’s lab, Harvard School of Dental Medicine. 2011-2015: Research project: the role of osteoblast-derived VEGF in osteoblast differentiation and bone formation during bone repair; the role of endothelial to mesenchymal transition in bone repair and regeneration. Research Fellow Laboratory of Oral & Maxillofacial Surgery, Peking University School of Stomatology. 2008- 2009: Research project: microRNA profiles in oral squamous cell carcinoma; Integrin family and EGF signaling in the lung metastasis of salivary cancer. Residency and Graduate Research Assistant Department of Oral & Maxillofacial Surgery, Peking University School of Stomatology. 2005-2008: Research project: the mechanisms of lung metastasis of salivary adenoid cell carcinoma.
Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods
is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA and has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory
Soil, Plant, Animal and Human Health. Old discoveries in physiotherapy, Veterinary Medicine and Agriculture, Computer science, Mathematics, Statistics, Chemistry, Physics and Philosophy
1948 born in Viitasaari, Central Finland, 1967 Secondary school graduate, Viitasaari, 1967-70 studies of computer science, mathematics, statistics, chemistry, physics and philosophy in Universities of Tampere and Jyvaskyla. 1977 Licentiate of Medicine, Helsinki University. 1991 Specialty General Practice, Helsinki University. 1992 (3 months) Studies in Acupuncture, Shanghai College of Traditional Medicine. 1953-84 working on my home farm with my family. 1977-78 physician of Sukeva prison (non-military service). 1978-85 periodic rehabilitation doctor (Peurunka Rehabilitation Center, Laukaa). 1985-89 physician, Health Center(physician-in-chief 1986-88). 1990 assistant physician, Hospital for Rheumatic Diseases, Heinola. 1990-2007 and 2009-11 rehabilitation doctor in Rehabilitation Hospital Vetrea Terveys Oy (first Iisalmen veljeskoti ja kuntoutuss airaala�) 2008 physician, Health Center of Ylä-Savon kttky, Iisalmi 2001-05 part-time rheumatologist, Iisalmen Aluesairaala 2002, Jan to March, 2 months, ward physician, Hospital for Rheumatic Diseases, Heinola. 2011 retired but working as a periodic rehabilitation doctor, Vetrea terveys Oy, Iisalmi. Since internet opening, in 1995, private studies via international libraries. Since the 1990s monthly or weekly discussions with prof. Osmo Hanninen and 2006-2014 with veterinary surgeon Seppo Haaranen on soil, animal and human health. Since 1993 publications in Suomen Laakarilehti (Finnish Mecical Journal), Duodecim, Bibliothek Forschung and (Journal of General Praxis), Jacobs Journal of Agriculture, Journal of African Association of Physiological Sciences and Biomedical Journal of Scientific and Technical Research
Radiology, Radiological Sciences, Radiation Medicine/Oncology, Critical Care Medicine, and Physics
DR. ALAIN L. FYMAT, BA, BS, MA, MS, PhD, PhD, is a medical-physical scientist and an educator who was educated at the Universities of Bordeaux and Paris-Sorbonne, France, and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, both Institutes located in Rancho Mirage, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine and Physics at several U.S. and European Universities (University of California at Los Angeles, University of Southern California, and Loma Linda University, California; University of Lille, France). Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of the Radiology Service, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Bio behavioral Research at the University of California at Los Angeles/Charles R. Drew University of Medicine and Science in Los Angeles, California. In an earlier research career, at the California Institute of Technology (Jet Propulsion Laboratory, a contractor of the U.S. National Aeronautics & Space Administration), Dr. Fymat was actively engaged in atmospheric sciences, the environment, climatology, and space exploration. He was an investigator in several Earth- and space-based experiments within the U.S. Earth and space exploration program. He was an Advisor to the U.S. National Research Council, National Academy of Sciences for its post-doctoral programs tenable at the Jet Propulsion Laboratory. His industrial experience was in the context of the U.S. Strategic Defense Initiative (Ballistic Missile Defense Program) researching and designing atmospheric probes and electromagnetic sensors operating in benign and stressful nuclear environments. Dr. Fymat’s current research interests lie at the interface between science and medicine (particularly molecular/personal/precision medicine, nanomedicine, nanotechnology, and human genetics/epigenetics/ecogenetics), He has extensively published (about 350 scholarly publications including patents, books & monographs, book chapters, refereed articles). He has received numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He has lectured extensively in several national and international academic, professional, governmental and industrial venues. He is Honorable Editor of the “International Journal of Cancer Prevention & Current Research” and the “International Journal of Nanomedicine Research”, and Editor of the “International Journal of Nanobiotechnology”, the “International Journal of Global Nanomedicine”, and the “International Journal of Tumor Medicine & Prevention”. He is a Board member of several institutions. He is also Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a past or current Member of several national and international professional societies (International Radiation Commission; American Association of University Professors; American Association of University Radiologists; American College of Radiology; Radiological Society of North America; California Radiological Society; Los Angeles Radiological Society; American Association of Physicists in Medicine; American Institute of Physics, among others). He is a frequent Plenary Invited Speaker at several international scientific conferences on nanomedicine, nanoscience & technology, pharmaceutics and drug delivery, among other topics. With interest in Africa, Dr. Fymat is also associated with the Society for the Advancement of Science in Africa (SASA) where he holds several executive positions (Vice Chair of the Board; Member of the Executive Council; Director of the Scientific Directorate; Chair of the Scientific Committee). He was also Chair of its Conference Programs (2013 in Polokwane, South Africa; 2014 in Kampala, Uganda; 2015 in Toronto, Canada; 2016 in Nairobi, Kenya; and later in 2017 in Kigali, Rwanda).
Clinical outcomes and basic science research to develop improvements and new technologies related to hip and knee arthroplasty: Osseointegration and methods to enhance it; Joint Arthroplasty Related Biomaterials; Hip and Knee Biomechanics; Bone graft substitutes; Additive manufacturing
Dr Michael Tanzer is an Orthopaedic Surgeon specializing in adult hip and knee arthroplasty. He obtained his medical degree and did his residency training at McGill University. He did an Adult Reconstruction Hip fellowship at Harvard University with Dr William Harris at the Massachusetts General Hospital. He then returned to the McGill University Hospital Centre (MUHC) in Montreal, Canada. He is the Associate Surgeon-in-Chief of Surgery at the MUHC and a Professor and the Vice Chair of Surgery at McGill University. He holds the Jo Miller Chair of Orthopaedic Research and is the Director of the McGill Arthroplasty Group. His research includes clinical, basic science and engineering related investigations related to hip and knee joint reconstruction. He has published over 130 papers and book chapters. His research has been recognized with 6 Hip Society Awards, 2 American Academy of Orthopaedic Surgeons Awards of Excellence and 2 Founders Medals. He is a member of the prestigious Hip Society and International Hip Society.
Otology and Audiology Rhinology, Allergic Rhinitis and Immunology Facial Plastic Surgery Sleep Disorders, Swallowing Disorders
Medical Doctor / Otorhinolaryngologist (2004), Deputy Director of Otorhinolaryngology Dept, Erzurum Training and Research Hosp (2008-2011), Observership at Yale UniversitySchool of Medicine (2013), Deputy Director of Otorhinolaryngology Dept, Eskisehir (2014), Associate Professor at Yunus Emre Gov Hosp (2015), Bachelor of Science in medicine, Hacettepe University, Faculty of Medicine, Ankara, TURKEY, 2000, Bachelor of Science in Otorhinolaryngology & Head and Neck Surgery, Ankara Training and Research Hospital, Otorhinolaryngology & Head and Neck Surgery, Ankara,TURKEY,2004, THESIS:The Role Of Electronystagmograpy In To Determine The Ethiology Of Vertigo, 2004, Associate Professor in Otorhinolaryngology & Head and Neck Surgery, Gazi University Hospital, Otorhinolaryngology & Head and Neck Surgery, Ankara,TURKEY,2015.
Interdisciplinary cooperation in the healthcare services Introduction of spinal manipulation and radiology in physical therapy programs Spinal manipulation Orthopedic rehabilitation Physical modalities and electrotherapeutics
James M. McKivigan, DPT, DC, PhD(c), MPA, MA is an associate professor in the School of Physical Therapy at Touro University Nevada. He began working at Touro in 2009. Dr. McKivigan received his Doctor of Physical Therapy at the University of Montana in 2013; Doctor of Chiropractic from Palmer College of Chiropractic in Davenport, Iowa in 2004; he is currently a PhD candidate at Northcentral University in Arizona. His initial Physical Therapy training was from the US Army-Baylor Program in Physical Therapy at Fort Sam Houston in San Antonio, TX in 1982; Master’s in Public Administration from Golden Gate University in San Francisco, CA in 1988; Master’s in Management from Webster University in St. Louis, MO in 1984; and Bachelors of Science in Physical Education from UC Berkeley in 1980. He is a retired Navy physical therapist, and he has served in a variety of clinical settings including acute care, rehab, home health, and outpatient care. He is active in professional associations including the American Physical Therapy Association 1981 – Present, Nevada Chapter of the American Physical Therapy Association, American Chiropractic Association 2004 – Present, Nevada Chiropractic Association 2005 – Present, U.S. Army-Baylor Alumni Association 2010 – Present, American Academy of Orthopaedic Manual Physical Therapists 2013 – Present, Society of Clinical Research Associates 2014 – Present.
Chronic diseases-diabetes, neurodegenerative diseases-prevention and treatments; Infectious diseases and cancer preventions and treatments; Oxidative and Nitrosative Stresses; Luminescence; Airborne and NSAID Toxicology; Diseases of Chickens and Dogs; Treatments for cataracts and retinopathy; Treatments for hypertension, neurological and nephrology diseases; Developments of new drugs to prevent pain sans side effects; Development of new approaches to viral treatments
The goal of my present research is to apply the knowledge gained from my recent research in diabetes in humans to prevent damage that occurs from the diabetic state. We know that the real cause of type I diabetes is a stimulated state of oxidative and nitrosative stress. This kills the Beta cell in the pancreas and eliminates the control between insulin secretion and the proper level of sugar in the blood. Replacing insulin does not eliminate the damage to the body caused by ongoing oxidative/nitrosative (O/N) stress. Type II diabetes is also controlled by O/N stress but at a slower rate of damage. I have studied oxidative stress for over 30 years since I was a pioneer in the development of cellular chemiluminescence which is dependent on the stimulation of neutrophils and macrophages a major portion of the body’s response to infection and disease. We wrote seven books on different aspects of chemiluminescence and luminescence for CRC press Boca, Raton Florida. We developed luminescence- based screening systems for antioxidants which identified the action of polyphenols and monophenols as important oxidative scavengers or antioxidants. In collaboration with Dr Robert Hoeldtke we studied oxidative stress in early type I diabetic patients and showed that urate is depleted 25% compared to controls each and every year for three consecutive years. This surely indicates that oxidative stress continues in early diabetic children and young adults which can lead to blindness. Therefore, the idea that continuous treatment of oxidative stress and early DNA damage that result from the stress might prevent the disease and/or the damage that can occur from the disease. Therefore, Dr. Jabbour who is a Harvard –trained world famous retinologist and myself decided to collaborate on a clinical trial to prevent blindness caused by either diabetes or age-related macular degeneration. Anecdotal data in two individuals indicated that multiple supplements given in a continuous manner can cause diabetics (that are on a continuous decline of their sight) to improve in their visual acuity. In order to prevent type I diabetes (TID) it is crucial to recognize the beta cell damage mechanism and the eventual target of damage. Our research and the research of others, indicate that the damage is caused by a nitric oxide-based oxidation of DNA. Therefore, changes causing non-repaired DNA damage are likely to kill the insulin–producing beta cell. Damage or mutational change could occur in either genomic or mitochondrial DNA of the beta cell. Therefore, we will measure both mitochondrial damage and demethylation of DNA-complex of the insulin gene. By screening both DNA damage mechanisms we may well detect the earliest detection point in time for TID. Early treatment to prevent this damage may well prevent TID.
Research in Pediatrics
Mao, Meng Education in Program for Hospital Management, China-Europe International Business School, National Institute of Public Health of Japan, Tokyo, Japan, JICA 2000 Seminar of Health Systems Management, School of Public Health, University of California at Berkeley, U.S.A, Post-doctoral fellow, School of Medicine, West China University of Medical Sciences, M.D, School of Medicine, West China University of Medical Sciences, B.A Academic Positioning as President, Chengdu Women’s and Children’s Central Hospital, Vice Dean, West China Medical School, Sichuan University, President, West China Second University Hospital, Sichuan University, Director of China Center for Birth Defect Monitoring, Professor, Department of Pediatrics, WCUMS
Human-Centered Computing, Data Analytics, High Performance Computing
Hong Lin received his PhD in Computer Science in 1997 at the University of Science and Technology of China. Before he joined the University of Houston-Downtown (UHD), he was a postdoctoral research associate at Purdue University; an assistant research officer at the National Research Council, Canada, and an engineer at Nokia, Inc. Dr. Lin is currently an associate professor with UHD. His research interests include parallel/distributed computing, grid computing, multi-agent systems, and high level computational models. He is a co-supervisor of the Grid Computing Lab at UHD. He is also a senior member of the Association for Computing Machinery (ACM).
Cancer Biomarker Discovery; Noninvasive Cancer Early Detection; Disease Diagnosis and Prognosis; Liquid Biopsy; Circulating Cell-free DNA/RNA/miRNA; Next-generation Sequencing; Digital Droplet PCR, Assay Development
Dr. Chen-Hsiung Yeh received his Ph.D. in Microbiology and Molecular Genetics from Rutgers University, and completed his post-doctoral training at Washington University School of Medicine at St. Louis. He has more than 20 years of experience in the biotech pharmaceutical and diagnostic clinical laboratory service industries. Currently, he is co-founder and Chief Scientific Officer at Circulogene Theranostics. He has held senior management positions in various companies including Vice President of Molecular Testing at Atherotech Diagnostics Lab; General Manager at Response Genetics; Scientific Director at Quest Diagnostics; and Principal Investigator at Pfizer. His expertise and experience includes drug discovery, molecular diagnostics, oncology and advanced technology. He is the author and inventor of more than 40 publications and patents.
Membrane proteins, X-ray crystallography, Computational Biology, Molecular Biology, Cell Biology and Neurobiology
Pius Padayatti did his Doctorate in Biochemistry (Under CSIR sandwich program from Cochin University of Science and Technology, Cochin, India and Semmelweis Medical University, Budapest). He did work on Molecular Neurosciences with special interest in G-protein coupled receptors. Later during his post-doctoral studies he got trained at the Department of Biochemistry, at Case Western Reserve University, Cleveland, Ohio, in membrane protein structural biology. Worked on single membrane spanning signaling molecules and their structure-function aspects. Also contributed significantly to antibiotic research in Industry-academic collaborations. Published several high impact papers on novel antibiotic design based on crystal structures. He later worked for Amgen (CRO Novacyte-Polgenix Inc) on their GPCR target projects and determined many ligand bound membrane protein structures. He worked in industry of automation of crystallization at Rigaku Automation and developed many novel algorithms for crystallization automation products. Currently he is work at The Scripps Research Institute, La Jolla, CA as staff at the Department of Structural and Computational Biology. Current interest is in membrane protein structure determination using LCP methods and XFEL techniques
Borrelia burgdorferi, Lyme disease, Caenorhabditis elegans, muscular dystrophy, cell shape maintenance, structural maintenance
Dr. Kelly Grussendorf is young and developing female scientist in the area of molecular, cellular and developmental biology. Her main area of focus is on the genetics and molecular mechanisms of different neuromuscular disorders. She also carries out studies to determine the prevalence and spread of the Lyme disease causing bacteria, Borrelia burgdorferi. She received her bachelor’s degree from the state school Minnesota State University, Moorhead. From there she continued to her PhD work at the University of Kansas where she worked with the model organism, Caenorhabditis elegans studying a human homologs role in membrane trafficking and cell shape maintenance, and disorders associated with the loss of this genes function. She is now an Assistant Professor at the University of Dubuque (UD), Iowa. At UD she works with students on these various research projects and teaches cell biology and anatomy and physiology courses.
Biologics Cellular Therapies & Tissue-based Products; Biomedical Product Development
CEO, CASCADE BIOTHERAPEUTICS, Inc. Bethesda, MD 2012 to present Genomic-based Diagnostics: Manage domestic and international collaborations to develop pharmacogenomic applications for personalized medicine, market cloud-based analytics, and mobility services to enterprise partners. Regulatory Strategy for Laboratory Developed Tests & Analytics: Collaborate with contract labs to design and validate molecular diagnostics. Plan data submission to obtain Z-codes for reimbursement. CEO, STRATEGIC CONCEPTS, LLC Washington, DC 2008 – 2012 Department of Veterans Affairs Subcontractor to Small Disabled Veteran Owned Business EHR Program Manager/Contractor: Established Program Management Office: deploy project management information management system, identify project standards, train staff, and define requirements for eHealth Record (EHR) supporting 300 Readjustment Counseling Centers in 50 states. Clinical Laboratory Practice- Program Manager/Contractor: Good Clinical Practice (GCP) Quality Assurance services for clinical trials conducted by the VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center Clinical Laboratory Information Management System: Coordinated the validation of a Laboratory Information Management System to support VA Office of R&D for their biomedical and clinical research programs across 88 research facilities. AMERICAN RED CROSS, BIOMEDICAL HEADQUARTERS Washington, DC Program Director, Quality Productivity & Effectiveness 2006-2007 Business Analytics & Laboratory Performance Excellence:. Utilized performance excellence to champion organizational performance, developed strategic initiatives to increase the financial productivity and effectiveness of 36 facilities and 5 regional diagnostic labs saving $50 million over 3 years. Compliance, Risk Management & Strategic Alignment: Collaborate with executive leaders across the enterprise to design and deploy strategies to ensure enterprise-wide compliance, sustain continuous improvement and align operations with evolving regulatory strategies for US and EU markets. Director, BIOMEDICAL HEADQUARTERS FACILITY QUALITY ASSURANCE, 2004 -2006 Data-Driven Decision Making for Innovation: Leveraged the power of business intelligence tools to identify previously unidentified opportunities for product and process improvement. Directed 5 data scientists in the development of customized reports to facilitate data-driven decision making to improve enterprise performance, lower costs, and ensure compliance with FDA regulations. FDA Regulatory Affairs & Biological Product Manufacturing: Reviewed facility SOPs, Biologic License Applications (BLAs), Chemistry Manufacturing and Controls (CMCs) and 483 responses to ensure the safety of products produced across a network of 36 biologics manufacturing facilities and 5 diagnostic laboratories Internal Audit Management: Audited facilities, IT systems and coordinated the development of 483 responses and corrective action plans. Deployed quality system innovations including software upgrades and lab equipment validation across a nation-wide network of 36 facilities generating $2 Billion FY2006 Quality System Performance Management: Conducted statistical research on key performance metrics, updated dashboards, and directed 3 data scientists in the development of customized reports to facilitate data-driven decision making supporting diagnostic labs and blood facilities.
Oncology, Biomarkers, Onco hematology
Research Realization of chemotherapy treatments, radiation therapy indication. Execution of Clinical Research of different gastric tumors, endocrine, Gist, esophageal, pancreas, breast with the use of drugs in clinical research allowed. Teaching lectures to the community and different thematic Television on cancer and the environment. Publications in various medical journals of Argentina and neighboringcountries. Clinical Oral Oncology, Oral Diagnostics, Premalignancy Diseases, Mammography.
Neurology and Neurosurgery
Douglas Gonsales, MD was born in Brazil where He did his graduation in Medicine and Neurosurgery. Since his graduation He already started doing a lot of research in neurosurgery and neuroscience field. He moved to United States many years ago to do research focused on Cerebrovascular, Vascular neurosurgery, Skull base surgery, Brain Tumor, Stroke, Endovascular treatment and others. Dr Gonsales is working on many researches projects with the entire team in Jacksonville-Florida, Baptist Neurological Institute with Dr. Ricardo Hanel. He has been worked also in Spine surgery when he was in Brazil but now he is focused more on vascular and tumor but he has an amazing knowledge in the entire field of neurology and neurological surgery. Prof Gonsales will give a great impact in Biomedical Research (BJSTR), in neurological surgery field.
TBI, PTSD, Autism, Asperger’s, ADD/ADHD, learning difficulties, stroke, personality disorders, addiction and other complicating diseases such as Alzheimer’s
Michelle Conover is a licensed psychologist and Q.M.E., trained at Pacifica, Fielding and UCLA. She specializes in clinical and forensic neuropsychology with particular training and experience with traumatic head injury and neurodegenerative diseases. She has worked with children, adults and geriatric populations as well as specific populations such as professional athletes and criminal offenders. She has treated individuals with TBI, PTSD, Autism, Asperger’s, ADD/ADHD, learning difficulties, stroke, personality disorder, addiction and other complicating diseases such as Alzheimer’s. She is the clinical director and owner of Southern California Neuropsychology Group in Woodland Hills, CA where she provides neuropsychological assessment, cognitive rehabilitation, and neuro-psychotherapy.
Medicinal and pharmaceutical chemistry with special emphasis on drug design and non‐invasive drug delivery into the central nervous system, Non‐invasive neuroprotective strategies via prodrug approaches, Neuropeptides as lead compounds for central nervous system drug design, Combinatorial lead optimization, NMR‐based structure elucidation, Phenolic antioxidants with special emphasis on estrogens and their analogues/derivatives, Mass spectrometry–based proteomics focusing on protein carbonylation and nitration, Chromatography‐coupled mass spectrometry‐based bioanalytical assay development
Dr. Prokais primary research interest has been on innovative and multidisciplinary projects focusing on medicinal chemistry‐driven drug design and delivery into the central nervous system with special emphasis on the brain and eye. These activities have been conducted in successful and productive research collaborations, principally with Dr. Laszlo Prokai, focusing on translation of basic science findings to drug leads. In particular, Dr. Prokais projects integrates medicinal chemistry, biopharmaceutics, pharmacokinetics, metabolism and drug distribution studies in early‐phase drug discovery and the development of neuroactive/neuroprotective agents. Their complimentary expertise have routinely been leading to the following activities; design and syntheses of complex organic and peptide‐based (pro)drug leads, and we employ in silico/biomimetic/in vitro assessments of physicochemical parameters important to select lead compounds for preclinical development, as well as follow up in vivo investigations involving biopharmaceutical analyses together with various neurochemical/pharmacological paradigms to ascertain the efficient central delivery of our agents. A best testimony of recent success of our lab has been published in Science Translational Medicine in 2015 describing the very first brain‐selective delivery of estrogens based on a unique bioprecursor prodrug approach. Their patented discovery is without precedent in the scientific literature.
Immunology in general; Innate Immune System, Adaptive Immune System, Vaccines and Vaccination and Clinical Immunology; Medical Microbiology & Immunology
Dr. ChateenIzaddin Ali Pambukborn in December 6 -1968 in Kirkuk city Iraq.Married,with 3 daughters. He has gain hisMsc. and Ph.D degree in Immunology and Medical Microbiology from college of medicine Univ. of Tikrit.He is one of the first Founders of the College of Dentistry in Tikrit Univ. He servedFirst as a lecturer in college of medicine dept. of Pharmacology Univ. of Tikrit.Then a lecturer in Dept. of Medical Microbiology at the same college. He also served as a Head of Oral Microbiology Dept. college of Dentistry since 1 July 2007 till 2012.Now he is an Ass. Prof.lecturer in college of Dentistry since 2005.He laid the groundwork for the Immunological research in his University by graduating post graduate students in clinical immunology and interleukin studies in correlation with different diseases. He is an Editorial and Reviewer for more than 3 scientific international American journals.He has a remarkable record of successful and productive research projects in the area of clinical immunology in Tikrit Univ
Impact of standard risk factors and biomarkers to various cardiovascular outcome measures and evaluating risk prediction models in order to prevention of the diseases and treatment of related risk factors
Suman is an Associate Database Administrator in the Division of Cardiovascular Medicine at Vanderbilt University Medical Center in Nashville, USA. He works in several NIH-funded projects and the Veterans Aging Cohort Study (VACS) examining associations between risk factors and cardiovascular outcomes. Prior to joining at Vanderbilt in 2015, he received his DSc diploma in Epidemiology from Erasmus University in the Netherlands and MSc in Mathematics and Statistics from Indian Institute of Technology, Kanpur in India. His research largely focuses on the investigation of risk prediction of complex diseases through modeling studies and evaluates the expected predictive ability of risk models using simulated data in order to justify whether empirical investigation is warranted. He is interested in advanced statistical modeling applied in health science, and methodological and analytical considerations in prediction research.
Vaccinology; Formulation Development (Solid dosage and Topicals); Cell Culture and Molecular Biology; Transdermal Delivery
Amit Kumar is currently working as Scientist III, Product Development at Recro Pharma, USA. He obtained his Ph.D. in Pharmaceutics in 2013 from University of Texas at Austin, Texas. He is a member of scientific societies including American Association of Pharmaceutical Scientists; Delaware Bioscience Association; Indian Pharmaceutical Congress, and Indian Society for Technical Education. He is reviewer for Drug Development and Industrial Pharmacy; AAPS PharmScitech; Journal of Controlled Release; Molecular Pharmaceutics; Colloids and Surfaces B: Biointerfaces; Journal of Pharmaceutical Sciences; Nanomedicine: Nanotechnology, Biology, and Medicine; International Journal of Nanomedicine; Research and Reports in Transdermal Drug Delivery; Clinical, Cosmetic And Investigational Dermatology; Vaccine: Development and Therapy; Elsevier (Book proposals); American Association of Pharmaceutical Scientist (Abstract screener). He is also serving in the editorial board of many renowned Journals.
Surgery of the hand; Surgery of the wrist and elbow, and Microsurgery
Gómez Hernándezs medical training includes a Fellow in wrist arthroscopy and small joints at the Miami Hand Center (USA), Training in Hand Surgery and Microsurgery at the Badia Hand to Shoulder Center (USA). Fellowship in Hand Surgery and Microsurgery at the Military Hospital "Carlos. J. Finlay ". Under the direction of surgeons of renowned worldwide prestige (Jorge Orbay MD, Alejandro Badia MD, Pablo Perez Cabdet). Originally from the City of Havana (Cuba), he completed his Residency in Orthopedic and Traumatological Surgery at the "Frank País" Orthopedic Teaching Hospital at the University of Havana where he received his Diploma as the best graduate of his course. He obtained his Medical Degree at the Higher Institute of Medical Sciences of Havana. He has presented some of his techniques in Congresses and has been invited to the Kaplan Institute to confer on Total Arthroplasty of Trapezius- Metacarpal Articulation and as Professor in Basic Basic Arthroscopy of wrist in Barcelona. He is a Member of the Spanish Society of Orthopedic and Traumatological Surgery (SECOT), member of the European Wrist Arthroscopy Society (EWAS), member of the Spanish Society of Hand Surgery (SECMA), member of the Spanish Association of Microsurgery ), Member of the ISSPORTH (International Society for Sport Traumatology of the Hand). International Member of the AAOS (American Academy of Orthopedic Surgeons, Member of the Arthritis Foundation.
Suicide Prevention, Intercultural Relationships and Mentorship
Deborah A. William’s career as a qualified mental health clinician with 20+ years of experience across multiple mental health settings, to include facility, staff, and program management began shortly after completing both my undergraduate and graduate degree. She has expertise in conducting client psychosocial assessments, developing and implementing individualized treatment plans, and providing both group and individual therapy. She has special interest in diversity, special populations including At-Risk youth, juvenile delinquents, Children and Youth populations, and intercultural/multiracial populations. She can offer exceptional leadership capabilities, with skills in delegating tasks, training staff, and evaluating performance. She is a team focused clinical manager with an emphasis on holistic care and client advocacy to improve quality of life and well-being. Adept at setting measurable goals and collaborating with partners and interdisciplinary team members while ensuring consistent compliance with organizational policies, industry standards, and regulatory requirements. She is respected by employers for the ability to effectively develop and manage programs, resolve conflict, and provide ongoing instruction and support in both policy and mental health issues.
Pattern Recognition, Data mining, Business Intelligence and Health Informatics
Dr. Sita Venkatraman is currently the Information Technology Lecturer and Discipline Leader for Business Information Systems. She earned her PhD in Computer Science, with a doctoral thesis titled “Efficient Parallel Algorithms for Pattern Recognition”, from National Institute of Industrial Engineering in 1993. In the past 25 years, Sitas work experience involves both industry and academics - developing turnkey projects for IT industry and teaching a variety of IT courses for tertiary institutions, in India, Singapore, New Zealand, and more recently in Australia since 2007. Sitas recent research areas are predominantly in Business Intelligence, Data Mining, Health Informatics, Information Security and Cloud Computing, and their application to various industry sectors. She has published eight book chapters and more than 100 research papers in internationally well-known refereed journals and conferences. Sita also serves as Program Committee Member of several international conferences and Senior Member of professional societies and editorial board of three international journals.
Molecular Biology, Physiology, Neuroscience, and Animal behavior
He Liu, is faculty member at Gannon University. He teaches introductory Molecular and Cellular Biology, Animal Physiology and lab, and Research Methods in Biology courses in the Biology Department. His research is on the environmental effects on and the molecular basis of animal physiology and behavior.
Reproductive pathophysiology (Fertility-Infertility), Oncopathology: Phytotherapeutics in Prostate, Breast & Testicular cancers, Phytotherapeutics & Reproductive pathophysiology,
Neurologist / Neurological Oncologist / Neuroscientist
1/2017 – Present Attending Neurologist (Locum) Franciscan Health East – Affiliated with Indiana University/ Purdue University Schoolof Medicine 5/2013 – Present President and Founder Neurology and NeuroOncology Consultant, LLC Providing specialized consulting services in Neurology and Neurological Oncology 5/2013 - Present Locum Attending Neurologist and NeuroOncologist CompHealth Practicing in 4 states: IL, IN, MO and KS
Microbiology and infectious disease, bio surveillance, genomics and machine learning and AI to analyze large (Big Data) disparate biological data sets
Schad has over 25years of experience in the area of biotechnology, business development,molecular biology, machine learning/AI, bioinformatics, medical informatics, genetics, biomarker discovery, in silico biology, clinical trials, oncology, genomics, and other “omics,”. He has combinedmyunique biological and technical expertise to manage engineering, biological research and IT programs. Most recently he had served as Group CSO of ArroGen LLC developing GWAS technologies for medical disease associations, forensic purposes and other related DNA genomic sciences. Previously, he served as CSO of Digital Infuzion and PI of the Defense Threat Reduction Agency DTRA, Biosurveillance BSVE program. As CSO Digital Infuzion he assisted the CEO in matters of strategy and scientific business direction. Also he oversaw the development of GeneBrain, a software tool that models large volumes of Big BiologicalData for monitoring, classification of samples, repository querying, biomarker identification, and the refinement and validation of hypothesis. Previouslyat RTI, he managed a diverse group of “wet” lab scientists, population epidemiologists and computational scientists. He also served as the Associate Director of Medical Informatics at The Cancer Institute of New Jersey, providing strategic planning to clinical, medical informatics, and biomarker discovery in cancer. Provided strategy and thought management as the Health Informatics Coordinator for the National Cancer Institute (NCI) in the Division of Cancer Control and Population Sciences. He served as Principal Investigator of the Genome Sequence Database (GSDB), one of four human genome databases in which all DNA sequences were to be submitted. Hehas applied Advanced Mathematical Models (AMMs) to analyze and identify unique data sets within large and complex biological data. Beginning his career, he worked on developing vaccines and pediatric vaccines for infectious disease at both Walter Reed Army Institute of Research (WRAIR) and at Praxis Biologics. He currently serves on several ad hoc National Institutes of Health (NIH) study sections and several Scientific Advisory Boards (SABs) including the PhRMA Foundation.
Psychometrics; Statistical analysis; Human factors and Ergonomics
Finkelman is an Industrial and Forensic Psychologist as well as a Certified Professional Ergonomist. He holds a Ph.D. in Industrial / Organizational Psychology from New York University and an M.B.A. in Industrial Psychology from the Bernard M. Baruch School of Business of The City College of The City University of New York (CUNY). He was a tenured full professor of Industrial Psychology at The City University of New York as well as Dean of Students at Baruch College. He also served on the Doctoral Faculty in Business, specializing in Organizational Behavior, at the Graduate Center of CUNY.
Mathematical Modeling; Numericaland Simulationanalysis; Mathematical Methods; Computer Technology and Programming
Cross River Univ. of Technology, CRS Lecturer – II 2003/Current Lecturing IBB College of Agriculture,Obubra, CRS Lecturer – III 2000/2003 Lecturing Spic & Span Nig, Ltd., Apapa - Lagos Asst.Com./Adm..1996/2000 Adm./Mkting N.Y.S.C. National Service 1994/1995 Teaching
Paediatric Orthopaedic especially Foot Deformity; Trauma; Paediatric Spine; Paediatric Hips and Osteogenesis Imperfecta
Waleed Kishta has completed his education at The Royal College of Physicians and Surgeons of Canada. Currently he is working at London Health Sciences Centre, The Pediatric Orthopaedic Society of North America, Previously in QEII Health Sciences Centre Foundation, IWK Health Centre, McGill University, Canada
Target deliver steroids , nanomicelles
Dr. Kishore Cholkarcompleted his Ph.D from University of Missouri Kansas City, USA. He is currently working as a Formulation Development Scientist (Project Lead) at Custopharm Inc, Carlsbad, California, USA. His work focuses mainly on development of specialty products for injections and topical application. He is an active member of American Association of Pharmaceutical Scientists (AAPS), Association for Research in Vision and Ophthalmology (ARVO), Pharmaceutical Sciences Graduate Student Association (PGSRM), United States Pharmacopeia and Ophthalmology group (OMICS). Dr. Cholkar received the First Best Poster Award from Ophthalmology group in 2014 at the Ophthalmology 2014, Baltimore, USA and Worldwide Outstanding Dissertation Honorable Mention Award in 2016 from UMKC, Missouri, USA. He is the first author of more than 15 scholarly articles in peer-reviewed journals and is credited with more than 400 independent citations on google scholar for his work.
Animal biology, especially reproductive biologyand development and variations of sexual cycles according to the external (seasonal variations, pollution) and internal factors (genetics, epigenetics, endocrinal); study of fish, amphibians, reptiles, rodents, invertebrates;histology, Immunohistochemistry; history of life science
Jean-Marie Exbrayat is a Professor at Lyon CatholicUniversity and Ecole Pratique des Hautes Etudes (France). He obtained a PhD in 1977 at the University of Montpellier (France), and a D. Sci. in 1986 at Paris 6 University. Being the head of a research unit, his research concerns the reproductive biology of bony fishes, amphibians, reptiles, mammals especially rodents, and some invertebrates, related to the environmental conditions comprising pollution, and embryonic development of rare animals. Among the methods used, histology was adapted to the study of preserved animals. Dr Exbrayat was the head of a specialized course in histology, and teaches animal biology, histology, embryology, history and philosophy of sciences. He supervised or co-supervised 28 PhD. He is the author or editor of 14 books, and numerous publications and communications in animal biology as well as in interdisciplinary works. He is a member of several scientific societies and international institute. He is member of editorial boardsand reviewerfor international journals, a co-editor of the collection "Science, History, Philosophy" published by a French Publisher, and president of the Interdisciplinary Institute of Epistemological Studies (IIEE).
Pharmacokinetics/ Pharmacodynamics (PK/PD) and the use of animal and organ models
Mariana Babayeva MD, PhD is an Associate Professor at Touro College of Pharmacy, New York, NY. In addition to her role at Touro, Dr. Babayeva is also an Adjunct Professor at Rockefeller University and Visiting Scientist at Arnold and Marie Schwartz School of Pharmacy of LIU. Dr. Babayeva has over 14 years of experience in clinical practice. She is recognized for her expertise in the pharmacokinetics and the use of animal and organ models. Dr. Babayeva has conducted several international research projects. Dr. Babayeva has been published in peer-reviewed journals and serving as an editorial board member of repute.
Cardiology; Clinical Research; Clinical Trials; Clinical Cardiology; Electrophysiology Research; Heart Failure; Non-invasive Cardiology; Medicine; Internal Medicine; Medical Education; Emergency Medicine; Medical Research; Echocardiography
Embodied cognition; Cognitive development/learning in children; The role of brain systems in cognition and thought; The impact of political, social, and cultural institutions on human thought and behavior
Jay Seitz was formerly a practicing neuropsychologist in Manhattan specializing in clinical neuropsychology with late-age adults. He has been licensed in New York for the professional practice of psychology since 1991. He has additional training in CBT (cognitive-behavioral therapy), REBT (rational-emotive behavioral therapy), the Gottman method (couples therapy), psychoanalytic therapy (Washington Square Institute), biofeedback and pain management, and neurocognitive rehabilitation for patients who have suffered damage to the brain. He was previously on the doctoral and graduate faculties of Adelphi University and the undergraduate and graduate faculties of New York University and City University of New York (CUNY, tenured 2001). He is currently writing a book on the evolution of intelligence in hominins from the perspective of cognitive neuroscience. He has published on the use and misuse of projective testing in children, the bodily basis of thought; the embodied nature of musical performance; the cognitive and educational value of modern dance and ballet; the role of the brain in spatial-temporal thinking; the political and cultural constraints on human creative behavior; as well as the neural, evolutionary, cognitive, and developmental origins of human creative thought. Dr Seitz has a longstanding and strong interest in the arts. He was vice president of the Board of Directors of the newly founded American Dance Museum (ADaM) and previously on the Board of Directors of the Dalcroze School of Music (now part of Lucy Moses School), both in New York City. He has formerly studied both music (contrabass, piano) and dance (choreography). He has a deep interest in the uses and abuses of power and has written on the uses and misuses of government propaganda during wartime.
Statistics, Mathematics, Biostatistics
Investigating the lamprey immune system
Dairy Processing and Technology; Food Bioprocess Technology; Food Fermentation and Biotechnology; Food Safety and Microbiology;
Post-doctoral Associate. University of Minnesota. St. Paul, Minnesota. (1997- 1999) ; Post-doctoral Associate. Rush University Medical Center. Chicago, Illinois. (1996-1997); Post-doctoral Associate. Rush University Medical Center. Chicago, Illinois. (1991-1993); Doctor of Philosophy. University of Kentucky. Lexington, Kentucky. (1988-1991); Master of Science. University of Georgia. Athens, Georgia. (1985-1987) ; Bachelor of Science. University of Mosul. Mosul, Iraq (1980-1984) ; High School Diploma. Kuwait High School, Kuwait. (1977-1980)
Public Health; Radiology
Master of Public Health. Johns Hopkins’s University. Expected 2018. Clinical Research Certificate. University of Pennsylvania, Philadelphia PA, expected 2018. Graduate certificate in Global Health. Johns Hopkins’s Bloomberg School of Public Health. June 2017 Arabic Board of Radiology ▪ Arabic Board of Medical Specialization, Damascus, Syria ▪ 2008 Doctor of Medicine ▪ Al-Nahrain University, Baghdad, Iraq ▪ 2003 Baccalaureate degree (Science) ▪ Al-Nidhamiya Secondary school, Baghdad, Iraq ▪ 1996
Neurological Diseases, Neurodegenerative Diseases, Electromyography, evoked Potentials, Nerve ultrasounds, Autoimmune Neuropathies
Advanced Techniques in Conduction nerve and Electromyography. April 1999. - Generalization and Advanced Techniques in Conduction nerve, Electromyography and Somatosensory Evoked Potentials. April 2002. - Generalization of electrophysiological techniques and its application. March 2004. - Electrodiagnostic techniques and technologic advances. November 2004. - Conventional EMG and single fiber EMG. Motor Evoked Potential. December 2005. - Clinical Neurophysiologic Technicians. June -December 2009.
Allosteric auto-inhibition regulation of protein lysine acetylation in Mycobacterium tuberculosis through Dynamics Network and Dynamic Simulation
Neurology and Neurosurgery
Dr. Margaret Simonian has (PhD) in Advanced Medicine from the Australian School of Advanced Medicine, Macquarie University, Australia. She currently works as a Senior Research Fellow at LA-Biomedical Research Institute at Harbor-UCLA, Neurology Dept. Her research interests focuses on utilizing Proteomics and Molecular Biology in biomarker discovery and drug development of diseases, such as Brain Arteriovenous Malformations (AVMs), Brain Tumors, Brain Aneurysms and Multiple Sclerosis. Her research on Brain AVMs was the first to utilize proteomics to identity protein targets for AVM vascular and molecular therapies post Radiosurgrey. She published numerous articles in peer reviewed journal and presented in many international conferences. Dr Simonian is Reviewer for the following Scientific Journals; Journal of Proteomics, Journal of Arthritis & Research Therapy and Journal of European Proteomics. She is also an Editorial Board Member for many scientific journals, such as Journal of Protein Science Research, Journal of Applied Biotechnology & Bioengineering, Journal of Data Mining in Genomics & Proteomics and Journal of Science publications. Dr. Simonian is Organizing Committee Member for the International Conference on Precision Medicine.
Restorative dentistry, Cariology, caries preventive measures, operative dentistry, esthetic dentistry, bonding and adhesive dentistry and recent techniques and materials related to conservative and minimal tooth preparations.
Dr. Ahmed Elmarakby was graduated at 1999 from the Faculty of Dentistry, Al-Azhar University, Cairo, Egypt. He got the Master Degree in Operative Dentistry from Al-Azhar University at the year 2008 then finished his PhD in Operative Dentistry from Al-Azhar University Faculty of Dentistry, Cairo, Egypt in the year 2013. He is A Lecturer in Operative Dentistry Department , Faculty of Dentistry,Al-Azhar University, Egypt.Now, he is Assistant Professor of restorative dentistry science, Alfarabi Colleges, KSA. He has published 10 papers in different international journals.He sheared two posters in the KSA at jan 2017 (in Riyadh) and March 2017 (in Mekka) and participated with 6 posters in6 global dental conferences all over the world. Also he has the letter of acceptance for 4 posters in 4 upcoming international conferences at this year 2017. He has got Editorial Board Memberships in International Journals eg. Journal of Oral Medicine, Modern Research in Dentistry and EC Dental Science
Increasing the efficiency and productivity in the exploration of bioactive compounds in rare and under-described Sonoran Desert plants; to develop more efficient and effective processes to search for potential drug leads that impact several disease states and biological systems (i.e. Alzheimer’s disease, human immune system). The ultimate goal of Dr. Veltri’s research is aimed at exploring phytochemistry and ethnopharmacology derived from the Sonoran Desert flora to discover and develop novel therapeutic agents from Natural Products for the treatment of human diseases.
Charles A. Veltri, Ph.D., Assistant Professor of Pharmaceutical Sciences. Dr. Veltri earned his B.S. degree in Biology from the University of Puget Sound. He received his Ph.D. in Medicinal Chemistry from the University of Utah-College of Pharmacy. He held a postdoctoral fellowship at Roche Diagnostics in Penzberg, Germany sponsored by the Deutscher Akademischer Austausch Dienst (German Academic Exchange Service). Dr. Veltri lectures on the medicinal chemistry of drugs used for diseases/disorders of the endocrine system and central nervous system. His research interests include exploring natural product lead compounds for drug development in terms of chemical biology and molecular pharmacology.
Arthroscopy and Sports Injuries of Knee, Shoulder and Ankle, Wrist and Sports Medicine
Dra. Alvarado grew up in Guayaquil-Ecuador. She graduated with honors from the State University of Guayaquil - Ecuador in 1999. In July 2008 completes its Graduate Orthopedist at the same University Hospital based in the Ecuadorian Institute SOCIAL SECURITY HOSPITAL. She attended some fellowships in arthroscopy knee, wrist, Shoulder and Sports Medicine in, SHOULDER INTEGRAL ECUADOR, Dr. Victor Naula, MILLENIUM CLINIC; and UHZ and Sports Medicine Institute at Doctors Hospital, Miami Florida DR. URIBE JHON 2011-2012 UNIVERSITY OF FLORIDA. She has received several awards, including First place work best type posters on the theme: Brodie abscess in patela in the First Congress of University Teaching Hospital System 2006 Guayaquil-Ecuador; She also received the award in the IOCIM CONGRESS "International Organization for Training And Medical Research" JUNE 2014: "TO OTHER BODY WITH THAT BONE" CAREER ACHIEVEMENT AWARD IOCIM and professional excellence. Tania entered as a University professor since 2003 at the Faculty of Social Communication until 2013 with chairs of First Aid and Legal Medicine, then become a teacher in the Faculty of Medicine at the Department of Orthopaedics 2013, at the STATE UNIVERSITY OF GUAYAQUIL, until now .In the same Faculty she taught Medical English in 2009; she is also teaching in the Orthopaedics Residency UNIVERSITY OF GUAYAQUIL FROM 2015. Enter as Teacher of the Department of Orthopaedics CATHOLIC UNIVERSITY OF MEDICINE OF Guayaquil from 2012 to the present. In 2008 performs MASTERS IN COMMUNICATION AND DEVELOPMENT and in 2010 -2012 performs MASTERS IN SUPERIOR EDUCATION TRAINIG IN UNIVERSITY OF GUAYAQUIL. In August 2009 Dra. Alvarado became TECHNICAL DIRECTOR OF RESEARCH AND TEACHING in her HOSPITAL during 3½ years until February 2013, performing 3 INTERNATIONAL MEDICAL CONGRESS, and Edit the first scientific journal of the Hospital. In 2011 she also became TECHNICAL CHIEF OF BONE BANK OF HOSPITAL ALCIVAR until today. Her clinical practice is broad-spectrum off Sports Medicine, Trauma surgery treats including, Knee, Shoulder, wrist artroscopic Procedures. Currently Tania is: Arthroscopy surgeon ALCIVAR HOSPITAL AND PANAMERICAN CLINIC. CHIEF OF ARTHROSCOPY REGIONAL HOSPITAL DR TEODORO MALDONADO CARBO IESS TECHNICAL DIRECTOR BANHUESOS S.A. HOSPITAL ALCIVAR DIRECTOR OF INTEGRAL KNEE ECUADOR TEACHING Orthopaedics STATE UNIVERSITY OF GUAYAQUIL AND CATHOLIC UNIVERSITY OF MEDICINE OF Guayaquil , Medicine Schol and Residency of Orthopaedics SCIENTIFIC SOCIETIES member recognized as SEOT, SLARD, ISAKOS, AAOS, SLAOT, ICRS, Arthroscopy GROUP ECUADOR. Tania has severals scientific publications and a book MEMORIES of: HISTORY OF HOSPITAL IESS HTMC.
Sperm analysis, Histopathology, Immunology
Clinical Orthodontics, Orthognathic Surgery, Maxillofacial Abnormalities, Craniofacial Abnormalities, Orthodontics, Acupuncture Points, Facial Pain, TMJ, Acupuncture Therapy
Multi-Modality Imaging and Theranostics, Cancer Imaging, Emerging Imaging Technologies, Non-Destructive, Non-Invasive, Minimally Toxic Imaging Technologies, Label-Free Imaging Modalities, Carbon-Fluorine imaging, Spectroscopy-Coupled Imaging Techniques, MRI, PET, CT, and Fluorescent-Based Technologies and Non-Fluorescent and Non-Radioactive Imaging
Dr. Farid Menaa is an inter- and multi-disciplinary professional. Professor, Director, Entrepreneur and Consultant, he was awarded with a National Master in Genetics in 1999 and PhD in Medicine (Geriatry/Gerontology, Biochemistry and Biophysics) in 2003, both with highest distinctions from prestigious French universities. Dr. Menaa followed a post-doctoral in Oncology as a NIH-fellow (San Diego, California, USA; 2004–2007), during which he discovered a novel radiation-induced DNA Damage Signaling Pathway. Subsequently, Dr. Menaa pursed his career in Dermatology and Stem Cells as a DFG-Fellow (Wuerzburg, Germany; 2007–2009), during which he pointed out the clinical relevance of skin cancer stem cells for prognosis, diagnosis and therapy. Dr. Menaa was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009–1010), during which he actively participated in the development of Carbon-Fluorine Spectroscopy (CFS, aka Spectro-Fluor™) for bio-medical and pharmaceutical applications. Further, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010–2012) during which he discovered new genetic variants of stroke in sickle cell anemia patients. Dr. Menaa followed various formations (Medecine, Pharmacy, Chemistry, Nanotechnology, Bioinformatics, Executive MBA in Entrepreneurship...). His main current focuses are related to personalized, translational and integrative medicine. Dr. Menaa has a strong experience with teaching, consulting, research, collaborations in several countries. Dr. Menaa is a member of several prestigious organizations (medical and scientific societies), editor and reviewer of a number of esteemed journals worldwide. Dr. Menaa authored and co-authored more than 100 publications, including in biophysics (including research and review articles, books and book chapters, proceedings, patents). Dr. Menaa is often invited as a speaker and chairman to reputed world congresses and institutions, and is offering speeches in various areas of medicine, sciences and technology.
Stem cell, Pharmacoepidemiology and Quality of Life Studies, Clinical Research, Bioequivalence studies, Product development
Dr. Prashant Pandya is GM, Program Management at Reliance Life Sciences, Mumbai, India. He has over 18 years of research experience (Academic & Industry) in various fields such as First in human studies, Stem cell research, Phase-II-IV clinical trials, Bioequivalence and QTC studies. He also serves on the Editorial Board member/ Active reviewer of several peer reviewed Pharmaceutical/ Life Sciences and Management journals. He has monitored and conducted more than 250+ national and global studies and has hands-on experience in the complete drug development process. He is a qualified Pharmacist, certified Project Manager & clinical research professional from Canada with Doctorate work in Pharmaceutical & Business Management. He was visiting fellow at Stanford University, USA.
Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): degree in biomedicine (2008), MSc (2010) and PhD (2014). His research involves neuropsychopharmacology, autonomic and cardiovascular pharmacology, cell signaling mediated by Ca2+ and cAMP. His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014). Since 1975, several clinical and experimental studies have reported that acute and chronic administration of L-type Ca2+ channel blockers (CCB), such as nifedipine, produces reduction in arterial pressure associated with a paradoxical increase of sympathetic activity. Despite this sympathetic hyperactivity has been initially attributed to adjust reflex of arterial pressure, the cellular and molecular mechanisms involved in this apparent sympathomimetic effect of the Ltype CCB remained unclear for decades. In 2013, Dr. Bergantin and collaborators discovered that this paradoxical increase in sympathetic activity produced by L-type CCB is due to interaction of the Ca2+/cAMP signaling pathways. Then, the pharmacological manipulation of the Ca2+/cAMP interaction produced by combination of the L-type CCB used in the antihypertensive therapy, and cAMP accumulating compounds used in the antidepressive therapy, could represent a potential cardiovascular risk for hypertensive patients due to increase in sympathetic activity. In contrast, this pharmacological manipulation could be a new therapeutic strategy for increasing neurotransmission in psychiatric disorders, and producing neuroprotection in the neurodegenerative diseases (Bergantin and Caricati-Neto, 2016 Eur J Pharmacol; Caricati-Neto et al., 2015 Pharm Res Perspect). Dr. Bergantin has published several articles in international journals (> 30), book chapters and an international book. He is member of several editorial boards of international journals (> 40, including editor-in-chief of 2 international journals). Dr. Bergantin has been frequently invited (every week) to be honorable guest (speaker) in international conferences.
Public health genetics/genomics including molecular biology, physiology, microbiology, family medical history, and social determinants of health
Dr. Apryl R. Brown is an adjunct science professor at Wayne County Community College District in Wayne County, Michigan where she is certified to teach introductory biology, human anatomy & physiology along with pathophysiology. Previously, she worked as a community education association for the University of Michigan School of Public Health Center for Public Health and Community Genomics. Dr. Brown is a past secretary of the American Public Health Association Genomics Forum whose purpose involves addressing the influence of genetics and genomics on the nationwide and global community. She has presented oral presentations regarding public health genetics/genomics at national as well as global conferences. Dr. Brown has a BS in Biological Sciences from Wayne State University, MD from Ross University School of Medicine, and a MPH in Health Systems Management from Tulane University School of Public Health and Tropical Medicine. As a result of successfully engaging in various public health endeavors, has led to Dr. Brown being the recipient of various awards and inducted into the Delta Omega Honorary Society in Public Health and Sigma Xi, The Scientific Research Honor Society.
My research project is entitled Coffee and Health. It is focused on quantitation of important healthy constituents present in the green and roasted coffee, known as chlorogenic acids. Today, it is well recognized the importance and the benefits of regular coffee intake to human health. Mounting evidence points to the chlorogenic acids content and other compounds present in the brewed coffee, as contributing to the prevention of neurodegenerative diseases such as Alzheimer’s and Parkinson’s; metabolic diseases as diabetes type II; depression, alcoholism, AIDS and various types of cancer. There are 3 sub-projects: 1) Identification of coffee consumption biomarkers and pharmacokinetic studies of chlorogenic acids in healthy volunteers; 2)Multi-centric study on coffee consumption, alcoholism, depression and academic performance; 3) Coffee consumption, CYP1A2 genotype, and caffeine metabolism. The first sub-project involves techniques utilizing high-performance liquid chromatography (HPLC), the second consist of an online survey and the third is based on molecular biology methodology such as real-time polymerase chain reaction (Real-time PCR).
Roseane Santos is a biomedical instructor of various topics in Pharmacology, Biochemistry and Molecular Biology Pharmaceutical Scientist on human research and product development, Clinical research on pharmacogenetics and pharmacogenomics, team leader and manager with the following strengths: Able to effectively communicate with colleagues at all organizational levels. Excellent personnel and team management skills. Highly organized with exceptional time management skills. Experienced in clinical trials phase I and II. Experienced educator, mentor and trainer
Adjunct Faculty, Department of Psychology & Neuroscience Program, Central Michigan University, Mt. Pleasant, USA Adjunct Faculty, Department of Biology, Saginaw Valley State University, Mt. Pleasant, USA Research Scientist, Field Neuroscience Institute, St. Mary’s of Michigan Postdoctoral Scholar, Department of Neurology, University of California at Los Angeles, Los Angeles Postdoctoral Scholar, Department of Medicine, University of California at Los Angeles, Los Angeles Postdoctoral Scholar, Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38105
Bio-process Development; Molecular Biology; Bioinformatics and Statistics; Basic and advanced Virology techniques; Cell culture; Immunology and Molecular Diagnostics; Bioanalytical techniques; Clinical diagnostics
Dr. Athmaram Thimmasandra Narayanappa obtained Masters and Ph.D degree in Biotechnology from Bangalore University. His Ph.D thesis was focused on Development of Subunit vaccine for Bluetongue viral disease under the mentorship of eminent Scientist Prof. Geetha Bali. He conducted postdoctoral research in the area of Bluetongue Virus Like Particles in the laboratory of renowned Virologist, Prof. Polly Roy at London School of Hygiene and Tropical Medicine, United Kingdom. He worked at prestigious Defense Research Development Organization , Government of India as Scientist and spearheaded the Bioprocess development research projects of Biodefence importance. He worked as Research Scientist at Virginia Tech, USA and discovered a highly pathogenic novel swine ortho-reovirus. In addition, he provided research coordination and project management support for industry sponsored project that focused on the development of diagnostics and vaccine against the novel virus. Dr. Athmaramhas extensively worked on developing and evaluating Bluetongue Virus Like Particle vaccine, Chikungunya Virus Like Particles, Swine Influenza subunit vaccine, Dengue virus specific diagnostic reagents. Dr. Athmaram has more than fifteen years of research experience in various disciplines of Life Science including recombinant protein production in yeast, baculovirus, bacterial and mammalian expression systems, development of molecular and serological diagnostics for various diseases of human and veterinary importance. He has published more than 30 research articles in peer-reviewed international journals, has 2 patents and received 2 national awards in India for his outstanding contribution in the field of Biotechnology. Currently Dr.Athmaram is working as R&D Scientist at Advanced Bio-Processing, BD Biosciences, MD,USA.
Medicine and Surgeries
Juan S Barajas-Gamboa is a Colombian-Born physician scientist. He received this Medical Doctor degree with honors from the Universidad Autonoma de Bucaramanga. He completed a Postdoctoral Research Fellow in clinical and translational research at the UCSD Moores Cancer Center followed by a Postdoctoral Research Fellow in Minimally Invasive Surgery, Robotic and Bariatric surgery at the UCSD Center for the Future of Surgery. He has already authored a clinical textbook of surgical pathology, authored several book chapters of robotic and bariatric surgery, and has had several peer-reviewed publications in high impact factor medical journals including the New England Journal of Medicine (NEJM), Cancer Research and Surgical Endoscopic. Moreover as a testament of his devotion to research, he serves as a reviewer, editorial board member, associate editor and senior editor for several international medical journals. He is active in the American College of Surgeons (ACS), Society American Gastrointestinal Endoscopic Surgeons (SAGES), The Society for Surgery of the Alimentary Tract (SSAT), American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH). Dr. Barajas-Gamboa’s research interests are focus on Minimally Invasive Surgery, Bariatric and Metabolic Surgery, Robotic surgery and Surgical Oncology; including basic sciences/translational research and clinical outcomes research.
Molecular Microbiology, Bio surveillance
Sunil Pandey is currently working as Graduate teaching assistant at Eastern Illinois University, Charleston, IL 61920, USA. Currently he is Vice-president of Society of Life Sciences Nepal, editor of International Journal of Medicine & Biomedical Sciences.
Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods
Dr. Alireza Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than one hundred reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Spain, Portugal, Mexico, Japan, Malaysia, Thailand, Taiwan, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books and book chapters in Chemistry. Syne, he has been awarded more than seven hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA.
Neuroanatomy, Histology & Embryology
• Arpan HALDAR MBBS, MD (Anatomy) from Utkal University, Bhubaneswar, Odisha. He is an Ex-Teaching Faculty, Department of Anatomy, ESI-Post Graduate Institute of Medical Science and Research, Joka, Kolkata under Ministry of Labour and Employment, Govt. of India. He is currently working as a Teaching Faculty for department of anatomy. All India Institute of Medical Sciences, Bhubaneswar under Ministry of Health and Family Welfare, Govt. of India. His Having more than 6 years of experience in teaching and research field.
Design of multi-target drugs supported by apatites
Soumia BELOUAFA received his degree extensive graduate studies from the Faculty of Sciences Ben MSik - Hassan II University in Chemistry of Technologically Advanced Materials in 2002 and his Ph.D. in 2006 from Process Engineering Laboratory in the Engineering Department Processes and Environmental at Faculty of Sciences and Technologies Mohammedia - Hassan II University. She then joined the same University as an administrator. In 2013, BELOUAFA joined the Department of Chemistry of Faculty of Sciences Ben MSik as an Assistant Professor in Chemistry and Bio Syntho laboratory as researcher Professor. She has published some papers in reputed journals. Her main research interest is design of multi-target drugs supported by apatites.
Statistics; Mathematics; Computing; Business Economics
Dr. Stephan Ogenstad is President of Statogen Consulting LLC, North Carolina since 2006, Founder and Principle of Innovalyst LLC, North Carolina, and In Silico Biosciences, Inc., MA. Dr. Ogenstad served as chief statistical advisor and reviewer to the Nobel Prize Committee for Medicine or Physiology, and was prior to 2006, Vice President of Biometrics at Vertex Pharmaceuticals in Cambridge, Massachusetts, USA. He has 25+ years of experience with major pharmaceutical companies and distinguished university hospitals from around the world. Dr. Ogenstad earned a PhD in Statistics from the University of Stockholm, Sweden, and served as professor of statistics at the Dept. of Statistics, University of Stockholm. He is an Adjunct Faculty Member and Professor of Biostatistics, Jiann-Ping Hsu College of Public Health, Georgia Southern University, a member of the International Advisory Committee of the University of North Carolina at Greensboro, USA, is President and Secretary of the North Carolina Chapter of the American Statistical Association, Program Chair for the Section on Statistical Consulting for the American Statistical Association, Member of the Clinton Health Access Initiative Clinical Advisory Board, Editor of MedCrave, Course Director of Biostatistics at Center for Professional Advancement, NJ, and President of the Swedish-American Chamber of Commerce of the Carolinas, Inc. Dr. Ogenstad today serves as a biostatistical expert witness in high-stakes pharmaceutical and medical device litigations, and is engaged in project collaborations with biotech, pharmaceutical, medical device companies, Massachusetts Institute of Technology, Georgia Southern University, and the Royal Institute of Technology, Stockholm, Sweden, where there are high-level strategy and problem solving challenges, where his expertise can become fully utilized. He is Novo Nordisks independent statistician for the LEADER and DEVOTE studies, in type-2 diabetes. Most of the project collaborations are as an expert biostatistician in pharmaceutical, device, and biotech submissions, where strategy and statistical specialty methods, high-intensity modeling and simulation, risk analysis and decision-making strategies are critical. Dr. Ogenstad also serves as chairman or independent statistician on Data and Safety Monitoring Boards. He interacts with FDA personnel at FDA committee meetings and FDA scientific advisory committee meetings on behalf of his clients. Dr. Ogenstad lectured and taught courses in experimental design, survey sampling, and drug development and in various other areas of biostatistics at the Karolinska Institute and the Swedish Academy of Pharmaceutical Sciences in Stockholm, Sweden. He is a frequent presenter at international conferences. Dr. Ogenstad has had numerous professional affiliations as well as society memberships. He has been the president of the Swedish Society for Medical Statistics, council member of the Swedish Statistical Association, council member and co-founder of the European Federation of Statisticians in the Pharmaceutical Industry, and chair of the Massachusetts Biotechnology Council, USA, Biostatistics and Data Management. During the past 25 years, he has held senior executive positions in nonclinical and clinical biostatistics and clinical data management with AstraZeneca, Parexel International Corporation, Amgen, and Vertex Pharmaceuticals. Dr. Ogenstad has been the lead statistician in the filing of 28 NDA, BLA, or PMA submissions in Europe, USA and Japan. He has more than 80 publications, book chapters, and presentations in the areas of biostatistics and medicine, and is a reviewer of Statistics in Medicine, Communications in Statistics - Simulation and Computation SAS Institute Inc, and Senior Editor for MOJ Clinical & Medical Case Reports.
Synthesis and characterization of: Polymers, Bio-polymers, IPN´s, Hydrogels, Composites, Lignocelluloses materials. Modelling and simulation. Nanotechnology
Norma-Aurea Rangel-Vàzquez realized in 2007 the research of Polyurethane Porous/Hydroxyapatite for Biomedical Applications: Synthesis and Characterization for the degree of PhD in Polymers Science (Mexico). Later, she carried out a postdoctoral study using computational modeling. To date, She has have published several papers in journals indexed in the Web of Science - Journal Citation Reports and in other journals, 2 books and chapters book (Wiley, CRC-Press Taylor, ELSEVIER and Science Publishing), memories of national and international congress. She has served as a reviewer for different journals such as: Journal of Applied Polymer Science, Materials Letters, Carbohydrate Polymers, Journal Polymer Engineering & Science, Thermochimica Acta, Journal of Molecular Structure, Journal of Surface and Coatings Technology, Academic Journal of Agricultural Research, World Journal of Engineering and Physical Sciences (WJEPS), Annual Research & Review in Biology, Journal of Applied Physical Science International, Global Conference on Polymer and Composite Materials 2015 and International Journal of Nanomedicine. She is leader of project of controlled release of antifungical with the participation of 14 countries. She is on the Editorial Board Member of several journals including, Journal of Pharmaceutics & Drug Development, Material Science and Engineering with Advanced Research, Journal of Nanomedicine Research, Nanomedicine Research Journal and Chemistry Journal.
Solid Dispersion; Transdermal; semisolid and liquid drug delivery; Abuse Deterrence; 3D Printing; Hot Melt Extrusion; Nanotechnology; Soft Gel Capsule
Conservative Dentistry, Dental Materials, Dental Technology, Prosthetics Dentistry
Male infertility; Reproductive biology; Spinal cord injury; Spinal cord injury model; Sperm motility; Sperm morphology; Sperm viability; Sperm count; RNA extraction; cDNA Synthesis
Pharmacovigilance; Clinical data management; Clinical research; Auditing and Quality management systems; Pharmacoeconomics